NCT03647137View on ClinicalTrials.gov

Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Parkinson's Disease
Interventions
OTHER

Detailed motor testing, including FoG, in PD subjects

"Subjects with PD with and without freezing of gait (FoG) will undergo a biomechanical assessment during a FoG provocation protocol in both the dopaminergic on and off state."

Trial Locations (1)

48105

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

VA Office of Research and Development

FED

NCT03647137 - Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD | Biotech Hunter | Biotech Hunter